Jiaoyuan Jia

Changchun, 130041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Corrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134].

Corrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134].

Journal: Journal of hepatology
Published: December 30, 2021

TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.

TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.

Journal: Journal of hepatology
Published: March 02, 2021

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.

Journal: Cellular and molecular gastroenterology and hepatology
Published: July 22, 2020

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.

Journal: International journal of molecular sciences
Published: June 29, 2020

Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.

Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.

Journal: Gut
Published: September 12, 2018

Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.

Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.

Journal: PloS one
Published: May 10, 2017

Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.

Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.

Journal: Cancer research
Published: February 20, 2017

Tumor protein D52-like 2 contributes to proliferation of breast cancer cells.

Tumor protein D52-like 2 contributes to proliferation of breast cancer cells.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 29, 2015

Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy.

Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 12, 2014

PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.

PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.

Journal: Anticancer research
Published: June 13, 2014

Inducing apoptosis effect of caffeic acid 3,4-dihydroxy-phenethyl ester on the breast cancer cells.

Inducing apoptosis effect of caffeic acid 3,4-dihydroxy-phenethyl ester on the breast cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: May 05, 2014

Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.

Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.

Journal: Oncology reports
Published: February 20, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026